Evidence map›Paper›PMID 34567617›Full record

ArticleMicrosystems & nanoengineering2020

On-chip multiplexed single-cell patterning and controllable intracellular delivery.

Zaizai Dong, Yanli Jiao, Bingteng Xie, Yongcun Hao, Pan Wang, Yuanyuan Liu, Junfeng Shi, Chandani Chitrakar, Stephen Black, Yu-Chieh Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microsystems & nanoengineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Microfluidic and Nanofluidic Intracellular Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Zaizai Dong *School of Biological Science and Medical Engineering, Beihang University, 100083 Beijing, China.
Yanli Jiao *College of Agricultural and Life Sciences, University of Florida, Gainesville, FL 32611 USA.
Bingteng XieCenter for Reproductive Medicine, Peking University Third Hospital, 100191 Beijing, China.
Yongcun HaoMinistry of Education Key Laboratory of Micro and Nano Systems for Aerospace, Northwestern Polytechnical University, 710072 Xi'an, China.
Pan WangCenter for Reproductive Medicine, Peking University Third Hospital, 100191 Beijing, China.
Yuanyuan LiuSchool of Biological Science and Medical Engineering, Beihang University, 100083 Beijing, China.ORCID 0000-0002-7836-941X
Junfeng ShiChemical and Biomolecular Engineering Department, Ohio State University, Columbus, OH 43209 USA.
Chandani ChitrakarDepartment of Biomedical Engineering, University of North Texas, Denton, TX 76207 USA.
Stephen BlackDepartment of Biomedical Engineering, University of North Texas, Denton, TX 76207 USA.
Yu-Chieh WangDepartment of Pharmaceutical Sciences, University of North Texas Health Science Center, Fort Worth, TX 76107 USA.
L James LeeChemical and Biomolecular Engineering Department, Ohio State University, Columbus, OH 43209 USA.
Mo LiCenter for Reproductive Medicine, Peking University Third Hospital, 100191 Beijing, China.
Yubo FanSchool of Biological Science and Medical Engineering, Beihang University, 100083 Beijing, China.
Lingqian ChangSchool of Biological Science and Medical Engineering, Beihang University, 100083 Beijing, China.
University of North Texas · USBeihang University · CNPeking University · CNThe Ohio State University · USNorthwestern Polytechnical University · CNUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional electroporation approaches show limitations in the delivery of macromolecules in vitro and in vivo. These limitations include low efficiency, noticeable cell damage and nonuniform delivery of cells. Here, we present a simple 3D electroporation platform that enables massively parallel single-cell manipulation and the intracellular delivery of macromolecules and small molecules. A pyramid pit micropore array chip was fabricated based on a silicon wet-etching method. A controllable vacuum system was adopted to trap a single cell on each micropore. Using this chip, safe single-cell electroporation was performed at low voltage. Cargoes of various sizes ranging from oligonucleotides (molecular beacons, 22 bp) to plasmid DNA (CRISPR-Cas9 expression vectors, >9 kb) were delivered into targeted cells with a significantly higher transfection efficiency than that of multiple benchmark methods (e.g., commercial electroporation devices and Lipofectamine). The delivered dose of the chemotherapeutic drug could be controlled by adjusting the applied voltage. By using CRISPR-Cas9 transfection with this system, the

Indexed as

BionanoelectronicsNanofabrication and nanopatterningNanostructures

Identifiers

PMID34567617
PMCPMC8433345
OpenAlexW3007536231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.